Bill introduced to provide incentives for the development of qualified infectious disease products
Senator Richard Blumenthal (D-CT) introduced S. 1734 – Generating Antibiotic Incentives Now Act of 2011. The bill provides incentives for the development of “antibiotic drug[s] for treating, detecting, preventing, or identifying a qualifying pathogen,” including, among other infectious agents, multi-drug resistant tuberculosis.
Learn more about the House companion bill (H.R. 2182).